Wenshen Xiaozheng Tang alleviates fibrosis in endometriosis by regulating differentiation and paracrine signaling of endometrium-derived mesenchymal stem cells
Wenshen Xiaozheng Tang reduced endometriosis fibrosis in mice and human cells by inhibiting eMSC differentiation into myofibroblasts and downregulating thrombospondin 4 paracrine signaling.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (46)
- [Adjunctive treatment of GnRHa combined wenshen xiaozheng decoction in treating endometriosis after laparoscopy: a clinical observation] via openalex
- Chinese Herbal Medicine, Alternative or Complementary, for Endometriosis-Associated Pain: A Meta-Analysis via openalex
- Chinese herbal medicine for endometriosis via openalex
- Effect of Shixiao San on inflammatory factors and pain in rats with endometriosis via openalex
- Endometrial adult/progenitor stem cells: pathogenetic theory and new antiangiogenic approach for endometriosis therapy via openalex
- Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosis via openalex
- Endometriosis via openalex
- Endometriotic Peritoneal Fluid Promotes Myofibroblast Differentiation of Endometrial Mesenchymal Stem Cells via openalex
- Human Endometrial Fibroblasts Derived from Mesenchymal Progenitors Inherit Progesterone Resistance and Acquire an Inflammatory Phenotype in the Endometrial Niche in Endometriosis via openalex
- Network pharmacology and experimental validation to explore the potential mechanism of Sanjie Zhentong Capsule in endometriosis treatment via openalex
- Therapeutic potential of Wenshen Xiaozheng tang, a traditional Chinese medicine prescription, for treating endometriosis via openalex
- Time to redefine endometriosis including its pro-fibrotic nature via openalex
- Traditional Chinese medicine prescription Guizhi Fuling Pills in the treatment of endometriosis via openalex
- Wenshen Xiaozheng Tang induces apoptosis and inhibits migration of ectopic endometriotic stromal cells via openalex
- W3134885188 via openalex
- W3135570571 via openalex
- W3149465127 via openalex
- W3165294846 via openalex
- W3175179742 via openalex
- W3176769346 via openalex
- W4210429357 via openalex
- W4229014180 via openalex
- W4234160457 via openalex
- W4280560903 via openalex
- W4281484584 via openalex
- W4281746308 via openalex
- W4312195631 via openalex
- W4388751842 via openalex
- W6605975336 via openalex
- W6711932193 via openalex
- W6807140714 via openalex
- W6810663529 via openalex
- W6849508421 via openalex
- W2058170926 via openalex
- W2304627954 via openalex
- W2464132584 via openalex
- W2536705733 via openalex
- W2580677672 via openalex
- W2753441688 via openalex
- W2804085153 via openalex
- W2909956232 via openalex
- W2912726271 via openalex
- W2946955396 via openalex
- W3027883984 via openalex
- W3035948690 via openalex
- W3045651959 via openalex
Cited by (3)
- Luoshi Neiyi prescription mitigates endometriosis by modulating nuclear receptor subfamily 5 group A member 1 methylation 2026
- Shaofu Zhuyu Decoction Inhibits Fibrosis in a Mouse Model of Endometriosis Through the Ampk/Tgf-Β1/Smads Pathway: Integrating Network Pharmacology and Experimental Validation in Vivo 2025
- Exploring the mechanism of Zishen Quyu Jiedu formula in treating endometriosis based on network pharmacology and experimental verification 2025
Source provenance
- europepmc
- last seen: 2026-10-12T06:17:10.165071+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-12T06:13:26.586950+00:00